NYSE$CTVA

Corteva Inc · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Corteva's first quarter results for 2021 reflected strong execution with increased sales and substantial Operating EBITDA growth.

Corteva reported strong first quarter results with net sales of $4.18 billion, a 6% increase compared to the prior year. The company's GAAP EPS was $0.81, up 125% from Q1 2020, and non-GAAP Operating EPS was $0.79, a 34% increase. Operating EBITDA increased by 14% to $904 million. Management increased full year 2021 net sales guidance to a range of $14.6 to $14.8 billion and affirmed full year 2021 Operating EBITDA guidance in the range of $2.4 billion to $2.5 billion.

  • Net sales and organic sales both increased 6% versus prior year, with gains reported in most regions, led by double-digit growth in Latin America.
  • Crop Protection net sales and organic sales both grew 12%, with double-digit net sales increases in every region.
  • Seed net sales rose 2% and organic sales grew 3% year over year, driven by continued new product penetration and local price gains.
  • Strong price execution and volume gains drove an Operating EBITDA increase of 14% to $904 million versus the same quarter last year.

Headline financials

Total Revenue

$4.18B

Previous: $3.96B+5.6%
EPS (adj)

$0.79

Previous: $0.59+33.9%
Free Cash Flow

$600M

Previous: $272M+120.6%
Net Income

$600M

Previous: $272M+120.6%
Operating Income

$512M

Previous: $357M+43.4%
Gross Profit

$1.76B

Previous: $1.69B+4.2%
Cash & Equivalents

$2.4B

Previous: $1.96B+22.5%
Total Assets

$42.5B

Previous: $43B-1.0%

Revenue & EPS history

Corteva · Revenue · Quarterly

$4.18B

Q1 2021+5.6%vs Q1 2020
Beat estimate in 7 of 11 quarters(64%)
ActualEstimate

Revenue by segment

Corteva · $4.18B total across 2 segments · Q1 2021

  • Seed
    $2.49B+1.5%
  • Crop Protection
    $1.69B+12.3%

Forward guidance

The Company increased its previously provided net sales guidance for the full year 2021 and now expects net sales in the range of $14.6 to $14.8 billion. Corteva affirmed its previously provided earnings guidance. Operating EBITDA is expected to be in the range of $2.4 billion to $2.5 billion and operating EPS range is expected to be between $1.85 and $1.95 per share.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

-0.1%

Avg return

Earnings day

+0.4%

Avg return

5 days after

+1.0%

Avg return

30 days after

59%

20 / 34 earnings

Positive

+18.0%

Q4 2023

Best reaction

-13.9%

Q4 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%-3.5%-8.1%
Q4 2025+0.9%-1.9%+2.6%
Q3 2025+1.8%+4.9%+5.6%
Q2 2025-0.2%+1.8%+1.8%
Q1 2025+7.0%+8.7%+14.7%
Q4 2024-2.3%-1.3%-5.1%
Q3 2024-5.0%-5.2%-3.7%
Q2 2024-4.6%-7.6%+3.2%
Q1 2024+5.3%+4.1%+3.3%
Q4 2023+18.0%+13.0%+17.1%
Q3 2023-9.7%-8.1%-8.4%
Q2 2023+0.2%-3.1%-8.6%
Q1 2023-6.2%-5.0%-7.8%
Q4 2022-3.8%-5.8%-1.2%
Q3 2022-2.3%+0.4%+0.6%
Q2 2022+3.9%+7.2%+9.9%
Q1 2022+1.4%-7.3%+8.3%
Q4 2021+1.3%+3.4%+7.4%
Q3 2021+10.6%+8.6%+7.5%
Q2 2021+5.9%+7.9%+6.3%
Q1 2021-4.1%-1.7%-7.5%
Q4 2020+2.8%+5.1%+8.1%
Q3 2020+3.1%+5.2%+17.4%
Q2 2020-11.3%-6.2%+2.7%
Q1 2020+1.0%-6.9%+17.1%
Q3 2017+2.6%+3.0%-18.9%
Q4 2017+2.6%+3.0%-18.9%
Q4 2019+4.0%+11.3%-2.2%
Q3 2018-4.7%-6.6%-5.3%
Q3 2019-4.7%-6.6%-5.3%
Q2 2018+2.5%+5.8%-4.8%
Q2 2019+6.6%+1.9%-0.6%
Q1 2019-13.9%-2.7%+2.7%
Q4 2018-13.9%-2.7%+2.7%
Q1 2018
Q2 2017
Q1 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro